Deep Learning for Basal Cell Carcinoma Detection for Reflectance Confocal Microscopy.

Journal: The Journal of investigative dermatology
Published Date:

Abstract

Basal cell carcinoma (BCC) is the most common skin cancer, with over 2 million cases diagnosed annually in the United States. Conventionally, BCC is diagnosed by naked eye examination and dermoscopy. Suspicious lesions are either removed or biopsied for histopathological confirmation, thus lowering the specificity of noninvasive BCC diagnosis. Recently, reflectance confocal microscopy, a noninvasive diagnostic technique that can image skin lesions at cellular level resolution, has shown to improve specificity in BCC diagnosis and reduced the number needed to biopsy by 2-3 times. In this study, we developed and evaluated a deep learning-based artificial intelligence model to automatically detect BCC in reflectance confocal microscopy images. The proposed model achieved an area under the curve for the receiver operator characteristic curve of 89.7% (stack level) and 88.3% (lesion level), a performance on par with that of reflectance confocal microscopy experts. Furthermore, the model achieved an area under the curve of 86.1% on a held-out test set from international collaborators, demonstrating the reproducibility and generalizability of the proposed automated diagnostic approach. These results provide a clear indication that the clinical deployment of decision support systems for the detection of BCC in reflectance confocal microscopy images has the potential for optimizing the evaluation and diagnosis of patients with skin cancer.

Authors

  • Gabriele Campanella
    Weill Cornell Medicine, New York, USA; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, USA.
  • Cristian Navarrete-Dechent
    Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA; Department of Dermatology, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Konstantinos Liopyris
    Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Jilliana Monnier
    Department of Dermatology and Skin Cancers, CHU la Timone, Aix-Marseille University, Marseille, France.
  • Saud Aleissa
    Dermatology Service, Division of Subspecialty Medicine, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA; Department of Dermatology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
  • Brahmteg Minhas
    Dermatology Service, Division of Subspecialty Medicine, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Alon Scope
    Medical Screening Institute, Chaim Sheba Medical Center, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Caterina Longo
    Department of Dermatology, University of Modena and Reggio Emilia, Modena, Italy; Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Centro Oncologico ad Alta Tecnologia Diagnostica-Dermatologia, Reggio Emilia, Italy.
  • Pascale Guitera
    Sydney Melanoma Diagnostic Centre, Faculty of Medicine and Health, Royal Prince Alfred Hospital and University of Sydney, Sydney, Australia; Melanoma Institute Australia, Sydney, Australia.
  • Giovanni Pellacani
    Facolta di Medicina et Chirugia, UNIMORE Iniversita Degli Studi di Modena e Reggio Emilia, Modena, Italy.
  • Kivanc Kose
    Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA. Electronic address: kosek@mskcc.org.
  • Allan C Halpern
    Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Thomas J Fuchs
    Weill Cornell Medicine, New York, USA; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, USA; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, USA. Electronic address: gac2010@med.cornell.edu.
  • Manu Jain
    Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, New York, 10021.